article thumbnail

Health Provider News

Hall Render

Grifols gets FDA approval for new facility in Clayton Invitae pledged $115M, 374-job investment in North Carolina. million donation The state’s troubled hospital grant program has finally awarded money to eight facilities. Many more are waiting. Supreme Court won’t hear COVID vaccine case filed by N.J.

article thumbnail

Health Provider News – February 10, 2023

Hall Render

Dunleavy proposes extending Medicaid coverage for new mothers ARIZONA Banner Health pays $1.25M penalty over HIPAA failures from 2016 breach Arizona nursing school at risk of losing accreditation St. billion since pandemic U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

Apparently, a fraudulent foreign-trained “doctor” treated the plaintiffs, none of whom claimed malpractice or any physical injury whatsoever. 2016) (association’s “adoption of rules, policies, and procedures. . . Such power rests solely with the FDA.” March 23, 2020), vacated , 15 F.4th 4th 259 (3d Cir. Reynolds Tobacco Co. ,

Doctors 52
article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

They’re experienced at what they do and aren’t intimidated by plaintiffs’ counsel and their threats of malpractice claims if they don’t testify the way plaintiffs want them to. procedure that existed at the time of [plaintiff’s] injury”; malpractice was “intervening cause”) (applying Kansas law); Eck v. 3d 1223, 1233 (11th Cir.

FDA 59
article thumbnail

Med-Mal Plaintiff Expert Standard of Care Opinion Unnecessary Due to FDA Warnings

Drug & Device Law

Of course, on the defense side, we’re usually as happy as clams if we can show that the Food and Drug Administration (FDA) has already decided which warnings are necessary, so let’s call it a day. Francisco is an unpublished, nonprecedential opinion about a medical malpractice, not product liability, case. 2023 WL 3589654 (Ariz.

FDA 59